Guardia Clausi, Mariano
Intranasal administration of aTf protects and repairs the neonatal white matter after a cerebral hypoxic-ischemic event. [electronic resource]
- Glia Oct 2012
- 1540-54 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
ISSN: 1098-1136
Standard No.: 10.1002/glia.22374 doi
Subjects--Topical Terms: 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase--genetics Administration, Intranasal Age Factors Animals Animals, Newborn Antigens--metabolism Apoproteins--administration & dosage Autophagy-Related Proteins Brain Injuries--etiology Bromodeoxyuridine--metabolism Caspase 3--metabolism Cell Death--drug effects Cell Proliferation--drug effects Cells, Cultured Cerebral Cortex--cytology Colchicine--pharmacology Corpus Callosum--drug effects Cytochalasin B--pharmacology Female Gene Expression Regulation--drug effects Green Fluorescent Proteins--genetics Humans Hypoxia--drug therapy Hypoxia-Ischemia, Brain--complications Intermediate Filament Proteins--metabolism Intracellular Signaling Peptides and Proteins--metabolism Lateral Ventricles--drug effects Male Mice Mice, Transgenic Myelin Basic Protein--metabolism Nerve Fibers, Myelinated--drug effects Nerve Tissue Proteins--metabolism Nestin Neurogenesis--drug effects Neuroprotective Agents--administration & dosage Oligodendroglia--drug effects Platelet-Derived Growth Factor--metabolism Proteoglycans--metabolism SOXB1 Transcription Factors--metabolism Time Factors Transferrin--administration & dosage